PA
PFE icon

Promethium Advisors’s Pfizer PFE Stock Holding History

Promethium Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Hold
81,378
– – 1.18% 26
2025
Q4 		$2.03M Sell
81,378
-21,642
-21% -$546K 1.09% 30
2025
Q3 		$2.62M Hold
103,020
– – 1.51% 20
2025
Q2 		$2.5M Sell
103,020
-75
-0.1% -$1.75K 1.52% 22
2025
Q1 		$2.61M Sell
103,095
-29,162
-22% -$763K 1.67% 18
2024
Q4 		$3.51M Sell
132,257
-1,380
-1% -$37.4K 2.4% 7
2024
Q3 		$3.87M Buy
+133,637
New +$3.9M 2.73% 3

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Promethium Advisors's PFE Position: Q1 2026 in Review

Promethium Advisors held its Pfizer (PFE) position steady in Q1 2026 at 81,378 shares worth $2.29M. The position accounts for 1.18% of the portfolio, ranked #26.

Promethium Advisors first reported a position in PFE in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.87M in Q3 2024. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Promethium Advisors held 81,378 shares of Pfizer worth $2.29M as of Q1 2026.
  • Promethium Advisors left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 1.18% of Promethium Advisors's portfolio in Q1 2026, its #26 holding.
  • Promethium Advisors first reported a position in Pfizer in Q3 2024 and has held it in 7 quarters since.
  • Promethium Advisors's Pfizer position peaked at $3.87M in Q3 2024.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Promethium Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.